Sinopharm
1099.HK
#2286
Rank
โ‚น741.35 B
Marketcap
โ‚น237.56
Share price
-0.48%
Change (1 day)
11.90%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.221 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.221 Trillion. In 2024 the company made a revenue of โ‚น7.221 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.609 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.221 T-5.1%
2023โ‚น7.609 T5.42%
2022โ‚น7.218 T-2.1%
2021โ‚น7.372 T16.85%
2020โ‚น6.309 T14.95%
2019โ‚น5.488 T21.52%
2018โ‚น4.516 T5.93%
2017โ‚น4.263 T27.22%
2016โ‚น3.351 T5.37%
2015โ‚น3.180 T9.14%
2014โ‚น2.914 T17.22%
2013โ‚น2.486 T25.94%
2012โ‚น1.973 T34.61%
2011โ‚น1.466 T55.34%
2010โ‚น944.02 B35.79%
2009โ‚น695.21 B37.56%
2008โ‚น505.40 B31.43%
2007โ‚น384.55 B40.26%
2006โ‚น274.16 B